A Delphi study on the clinical management of age-related macular degeneration

Gomes, Nuno; Meireles, Angelina; Carneiro, Ângela; Silva, Rufino; Campos, António; Duarte, Lilianne; Flores, Rita; Marques-Neves, Carlos; Abreu, Carolina; Peralta-Amaro, Ana Lilia; Beato, João; Amaro, Miguel Hage; Cabral, Diogo; Cachulo, Maria da Luz; Canelas, Joaquim; Carvalho, Rui; Coutinho, André; Correia, Nuno; Falcão, Manuel; Farinha, Cláudia; Figueira, João; Fonseca, Sofia; Fraga, Filipe; Furtado, Maria João; Isidro, Filipe; Lume, Miguel; Macedo, Marta; Marques, Inês; Marques, João Pedro; Mendonça, Luís; Mira, Filipe; Monteiro, Sérgio; Monteiro, Sílvia; Negrão, Pita; Neves, Pedro; Ornelas, Mário; Penas, Susana; Pereira, Sara Silva; Pereira, Sergio Nunes; Pessoa, Bernardete; Pires, Isabel; Roque, José; Ruão, Miguel; Santos, Gil Calvão; Silva, Filomena; Teixeira, Carla; Teixeira, Susana

doi:10.1007/s10792-021-02177-2

Cited by 4 publications

(1 citation statement)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…GA is one of the leading causes of vision impairment with an estimated 1 in 29 people over the age of 75 in the USA currently living with GA. 4 5 Recently, the eye care community has made strides in closing knowledge gaps surrounding the diagnosis and treatment of AMD through Delphi studies. [6][7][8][9][10] However, there are currently no peer-reviewed publications specific to a Delphi panel centred on diagnosis, management and treatment of GA. With a paradigm shift in GA treatment options now available, this study aims to improve current understanding of how this condition is viewed by achieving consensus surrounding diagnostic criteria, improve patient referral patterns and optimise management and treatment strategies for patients with GA.…”

Section: How This Study Might Affect Research Practice or Policymentioning

confidence: 99%

Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment

Kaiser,

Karpecki,

Regillo

et al. 2023

BMJ Open Ophth

View full text Add to dashboard Cite

Background/aimsWith a paradigm shift in geographic atrophy (GA) treatments now available, establishing consensus on the identification and diagnosis of the disease along with considerations for management of patients with GA will assist eye care professionals (ECP) in their day-to-day practices, leading to improved patient outcomes.MethodsA modified Delphi panel process (Geographic Atrophy Management Consensus) consisting of three total surveys and one virtual live meeting held between survey 2 and survey 3. Data were collected from July to October 2022. Participants included expert members of the eye care community that have demonstrated outstanding leadership among peers: a steering committee with three ECPs and a 15-member panel divided between five optometrists, five comprehensive ophthalmologists and five retina specialists. Consensus on statements related to the management of patients with GA was calculated using the RAND/UCLA Appropriateness Method.ResultsAt the conclusion of the third survey, consensus was reached on 91% of the 77 statements. Critical consensus topics include: (1) optical coherence tomography as the favoured method to diagnose and monitor GA, (2) preferred practice patterns regarding referral of patients to retina specialists and (3) treatment criteria given the advent of emerging therapeutics for GA.ConclusionsGenerating awareness of early signs of disease development, progression and identifying the best tools to evaluate GA establishes ideal management and referral strategies. Given the paradigm shift in GA management driven by approved therapies, coupled with the fact that the disease is progressive resulting in devastating vision loss, these strategies are critical to ensure best overall outcomes.

show abstract